Downloadable Slidesets with ExpressPoints

Share

Program Content

Activities

  • HER2 BC + Brain Mets
    Managing Patients With HER2+ Breast Cancer and Brain Metastasis: Slides
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 02, 2021

    Expires: February 01, 2022

  • Testing for HER2 BC
    HER2 Testing and Treatment Decisions In Breast Cancer: Slides
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 02, 2021

    Expires: February 01, 2022

  • Treating HER2+ EBC
    Expert Guidance on the Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer: Slides
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 02, 2021

    Expires: February 01, 2022

  • Treating HER2+ MBC
    Therapeutic Strategies for HER2-Positive Metastatic Breast Cancer: Slides
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 03, 2021

    Expires: February 02, 2022

  • <i>EP</i>: HER2+ BC Tx
    ExpressPoints: HER2-Positive Breast Cancer: A Guide Through an Evolving Treatment Landscape
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 09, 2021

    Expires: February 08, 2022

Faculty

cover img faculity

Jame Abraham, MD, FACP

Chairman
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Hope S. Rugo, MD

Clinical Professor of Medicine
UCSF Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Genentech, a member of the Roche Group

Puma Biotechnology, Inc.